INSIGHT MOLECULAR DIAGNOSTICS INC.
NPI 1427580109
Clinical Medical Laboratory in Nashville, TN
About Insight Molecular Diagnostics Inc. NPPES
Official registry information on file with the National Plan and Provider Enumeration System.
INSIGHT MOLECULAR DIAGNOSTICS INC. (NPI 1427580109), doing business as Oncocyte Corporation, is a healthcare organization registered as a clinical medical laboratory in Nashville, Tennessee and active in the NPI registry since March 2017. The organization holds a CLIA Certificate of Compliance certificate valid through December 21, 2027 and lists Sandra Odonald, Svp, Business Operations, as its authorized official.
NPPES Registry Identity
Specialties & Licenses
Other Names 1
CLIA Laboratory Certificates CMS CLIA
Laboratory certificates issued under the Clinical Laboratory Improvement Amendments (CLIA) program, which sets federal quality standards for human laboratory testing in the United States. There is no official CMS crosswalk between CLIA and NPI numbers; these certificates are associated with this NPI by matching facility names, locations and phone numbers in the CMS CLIA registry.
Certificate of Compliance 44D2335970
Insight Molecular Diagnostics Inc · Nashville, TNFrequently Asked Questions NPPES & CMS
Common questions about this NPI record, answered from the official NPPES registry and CMS datasets shown on this page.
What is Insight Molecular Diagnostics Inc.'s NPI number?
The NPI number for Insight Molecular Diagnostics Inc. is 1427580109. It was assigned to this organization in the NPPES registry on March 31, 2017. The provider was formerly known as Oncocyte Corporation.
Where is Insight Molecular Diagnostics Inc. located?
Insight Molecular Diagnostics Inc. is located at 2 International Plz Ste 510, Nashville, TN 37217. The listed phone number is (949) 569-9300.
What is Insight Molecular Diagnostics Inc.'s specialty?
The primary specialty registered for this NPI is Clinical Medical Laboratory with taxonomy code 291U00000X.
Does Insight Molecular Diagnostics Inc. hold a CLIA laboratory certificate?
Yes. A Certificate of Compliance (number 44D2335970) is associated with this NPI, valid through December 21, 2027. CLIA certificates authorize laboratory testing under the federal Clinical Laboratory Improvement Amendments program.
When was this NPI record last updated?
The NPPES record for Insight Molecular Diagnostics Inc. was last updated on April 30, 2026. NPI Profile syncs weekly with the NPPES registry data releases published by CMS. This NPI record was last updated 3 months ago. If this record has changed at CMS more recently, you can request an on-demand re-check against the live CMS registry, directly from this page.